<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02244892</url>
  </required_header>
  <id_info>
    <org_study_id>IRB 04-14-30</org_study_id>
    <nct_id>NCT02244892</nct_id>
  </id_info>
  <brief_title>Correlation of Scheimpflug Densitometry Measurements of Corneal Haze With Disability Glare</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Angela Zhu</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospitals Cleveland Medical Center</source>
  <brief_summary>
    <textblock>
      Disability glare is described as &quot;halos&quot; or &quot;starbursts&quot; around bright sources of light that&#xD;
      can cause discomfort and reduce vision. The cornea is the clear &quot;window&quot; at the front of the&#xD;
      eye, but certain conditions such as a previous infection can leave a scar. Corneal scars can&#xD;
      cause disability glare by scattering and spreading incoming light instead of allowing it to&#xD;
      focus on the back of the eye (retina) to get a crisp image. In this study, the corneal scar&#xD;
      will be analyzed using a new device that measures scar density (Pentacam), and a relationship&#xD;
      with disability glare will be made. This can help us further understand disability glare and&#xD;
      make better decisions in the future on when to treat these scars to help patients see better.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Disability glare is a phenomenon commonly described as starbursts and halos that results in&#xD;
      difficulty seeing clearly in the presence of bright &quot;blinding&quot; light. It can appear as if a&#xD;
      veil of light is cast over the world outside. Optically, this occurs when incoming light is&#xD;
      scattered in the eye instead of being focused on the retina. This is called straylight, and&#xD;
      it diffusely illuminates the retina which causes desensitization of the photoreceptors and&#xD;
      reduces the contrast of the retinal image (Lombardo &amp; Lombardo, 2010). The main sources of&#xD;
      scatter in the human eye are opacities in the clear ocular media, primarily due to diffusion&#xD;
      and loss of transparency in the cornea and lens, as well as within the retina. While the lens&#xD;
      is the largest contributor to light scatter (especially with cataract formation and aging),&#xD;
      opacification of the cornea (e.g. scars or haze) can similarly cause intraocular light&#xD;
      scattering, resulting in disability glare and decreased contrast sensitivity (Fan-Paul et&#xD;
      al., 2002).&#xD;
&#xD;
      Due to the subjective nature of disability glare and contrast sensitivity, it is fairly&#xD;
      difficult to develop a reliable objective way to measure and quantify this phenomenon. One of&#xD;
      the most commonly used clinical tests for disability glare is the Brightness Acuity Tester&#xD;
      (BAT), which is described as an ice cream scooper 60 mm in diameter with a 12 mm hole in the&#xD;
      center. With the patient viewing a visual acuity chart through the hole, a uniform luminance&#xD;
      at three different settings-high (white sand beach), medium (clear day), low (overhead&#xD;
      lighting)-is used to induce glare and simulate the various real-life conditions. The drop in&#xD;
      visual acuity with the various glare settings is used as a measure of disability glare. The&#xD;
      BAT test has been found to be a reliable predictor of outdoor visual acuity (clinically&#xD;
      validated for use in measuring disability glare secondary to cataracts), is ubiquitously&#xD;
      available, and is easy to administer. To further and more accurately reflect real life&#xD;
      situations, it can be used in conjunction with a contrast sensitivity chart rather than the&#xD;
      regular black-on-white Snellen letter chart (Aslam et al., 2007). Contrast sensitivity can be&#xD;
      tested using letter-based charts (e.g. Pelli-Robson letter sensitivity chart) that consist of&#xD;
      letters of the same size but with decreasing contrast, or contrast gratings, which are based&#xD;
      on sinusoidal waves of light (e.g. Vistech MCT-8000 or FACT).&#xD;
&#xD;
      Opacification of the cornea in the form of scars or haze is a natural response to a wide&#xD;
      array of pathological insults (e.g. infection, degeneration, corneal dystrophies) and can&#xD;
      result in light scatter and glare. Measurement of corneal haze was previously crudely&#xD;
      performed via standard slit-lamp examination and human measurement. Recently, an automated,&#xD;
      non-invasive, and objective method to measure corneal scar density was introduced using&#xD;
      Scheimpflug imaging. This Pentacam device (Oculus Optikgerate GmbH, Wetzlar, Germany)&#xD;
      consists of a rotating camera that captures images of the cornea at an angle, and analysis of&#xD;
      these anterior segment images can be employed to quantify scattered light in various&#xD;
      diameters and depths of the cornea. The generated maps of the amount of scatter in different&#xD;
      regions of the cornea are called corneal densitometry maps, and they are displayed along with&#xD;
      maps of corneal topography (elevation) and pachymetry (thickness). Normative values for&#xD;
      Scheimpflug densitometry have recently been established (Dhubhghaill et al., 2013).&#xD;
      Measurements have also been obtained after various surgical procedures to analyze their&#xD;
      impact on corneal clarity. This includes analysis of corneas after refractive surgery such as&#xD;
      LASIK (Cennamo et al., 2011; Fares et al., 2012) and PRK (Takacs et al., 2011), as well as&#xD;
      various forms of corneal transplantation (Koh et al., 2012; Bhatt et al., 2012;&#xD;
      Arnalich-Montiel et al., 2013; Ivarsen &amp; Hjortdal, 2013) and collagen cross-linking&#xD;
      (Gutierrez et al., 2012; Greenstein et al., 2010). Furthermore, it has been used to&#xD;
      characterize pathological conditions including infectious keratitis (Otri et al., 2012;&#xD;
      Orucoglu et al., 2014) and congenital corneal opacities (Elfein et al., 2013). However, no&#xD;
      functional correlation has been made with these anatomical maps, and the relationship between&#xD;
      scattered light as measured by densitometry and its effect on visual function such as&#xD;
      contrast sensitivity and disability glare has not been well-characterized.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2014</start_date>
  <primary_completion_date type="Anticipated">September 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Disability glare</measure>
    <time_frame>1 year</time_frame>
    <description>BAT measurements of disability glare</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual quality</measure>
    <time_frame>1 year</time_frame>
    <description>NEI-VFQ25 questionnaire on functional visual quality</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Contrast sensitivity</measure>
    <time_frame>1 year</time_frame>
    <description>Vistech contrast grating test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual acuity</measure>
    <time_frame>1 year</time_frame>
    <description>Visual acuity measured by Snellen chart</description>
  </primary_outcome>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Vision Disability</condition>
  <eligibility>
    <study_pop>
      <textblock>
        This will be a prospective study in which all eligible and willing patients will undergo&#xD;
        the same workup. The expected duration is 1 year, and the trial will be stopped once the&#xD;
        needed number of subjects has been enrolled. Testing will be performed on the day of the&#xD;
        routine clinical visit and will only extend the appointment by less than 30 minutes.&#xD;
&#xD;
        All patients receiving ophthalmological care at University Hospitals (both at the main Case&#xD;
        Medical Center site and the satellite offices at Westlake and Landerbrook) who meet the&#xD;
        inclusion and exclusion criteria would be eligible for this study. Subjects will be&#xD;
        identified who have an isolated corneal scar in one eye and otherwise healthy eyes with no&#xD;
        clinical evidence of lens or retinal pathology. Patients will be enrolled between September&#xD;
        6, 2014 and September 5, 2015, with the goal of recruiting at least 80-100 subjects.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18 years or greater&#xD;
&#xD;
          -  Presence of corneal scar in one eye&#xD;
&#xD;
          -  No clinical evidence of any other intraocular pathology&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Clinical evidence of other ocular pathology (e.g. cataracts)&#xD;
&#xD;
          -  Pediatric patients less than 18 years old&#xD;
&#xD;
          -  Bilateral corneal pathology&#xD;
&#xD;
          -  Presence of active corneal inflammation/infection&#xD;
&#xD;
          -  Presence of degenerative corneal disease&#xD;
&#xD;
          -  History of prior corneal surgery (e.g. corneal graft)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Hospitals Case Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rony R Sayegh, M.D.</last_name>
      <phone>216-844-8472</phone>
      <email>rrs109@case.edu</email>
    </contact>
    <contact_backup>
      <last_name>Loretta Szczotka-Flynn, O.D., Ph.D.</last_name>
      <phone>216-844-3609</phone>
      <email>Loretta.Szczotka-Flynn@uhhospitals.org</email>
    </contact_backup>
    <investigator>
      <last_name>Rony R Sayegh, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Angela Y Zhu, B.S.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shipra Gupta, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Danielle Alperin, O.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Fan-Paul NI, Li J, Miller JS, Florakis GJ. Night vision disturbances after corneal refractive surgery. Surv Ophthalmol. 2002 Nov-Dec;47(6):533-46. Review.</citation>
    <PMID>12504738</PMID>
  </reference>
  <reference>
    <citation>Aslam TM, Haider D, Murray IJ. Principles of disability glare measurement: an ophthalmological perspective. Acta Ophthalmol Scand. 2007 Jun;85(4):354-60. Epub 2007 Feb 20. Review.</citation>
    <PMID>17313443</PMID>
  </reference>
  <reference>
    <citation>Lombardo M, Lombardo G. Wave aberration of human eyes and new descriptors of image optical quality and visual performance. J Cataract Refract Surg. 2010 Feb;36(2):313-31. doi: 10.1016/j.jcrs.2009.09.026. Review.</citation>
    <PMID>20152616</PMID>
  </reference>
  <reference>
    <citation>Ní Dhubhghaill S, Rozema JJ, Jongenelen S, Ruiz Hidalgo I, Zakaria N, Tassignon MJ. Normative values for corneal densitometry analysis by Scheimpflug optical assessment. Invest Ophthalmol Vis Sci. 2014 Jan 7;55(1):162-8. doi: 10.1167/iovs.13-13236.</citation>
    <PMID>24327608</PMID>
  </reference>
  <reference>
    <citation>Cennamo G, Forte R, Aufiero B, La Rana A. Computerized Scheimpflug densitometry as a measure of corneal optical density after excimer laser refractive surgery in myopic eyes. J Cataract Refract Surg. 2011 Aug;37(8):1502-6. doi: 10.1016/j.jcrs.2011.03.037.</citation>
    <PMID>21782093</PMID>
  </reference>
  <reference>
    <citation>Fares U, Otri AM, Al-Aqaba MA, Faraj L, Dua HS. Wavefront-optimized excimer laser in situ keratomileusis for myopia and myopic astigmatism: refractive outcomes and corneal densitometry. J Cataract Refract Surg. 2012 Dec;38(12):2131-8. doi: 10.1016/j.jcrs.2012.07.041. Epub 2012 Oct 18.</citation>
    <PMID>23084157</PMID>
  </reference>
  <reference>
    <citation>Takacs AI, Mihaltz K, Nagy ZZ. Corneal density with the Pentacam after photorefractive keratectomy. J Refract Surg. 2011 Apr;27(4):269-77. doi: 10.3928/1081597X-20100618-02. Epub 2010 Jul 1.</citation>
    <PMID>20672772</PMID>
  </reference>
  <reference>
    <citation>Koh S, Maeda N, Nakagawa T, Nishida K. Quality of vision in eyes after selective lamellar keratoplasty. Cornea. 2012 Nov;31 Suppl 1:S45-9. doi: 10.1097/ICO.0b013e318269c9cd. Review.</citation>
    <PMID>23038035</PMID>
  </reference>
  <reference>
    <citation>Bhatt UK, Fares U, Rahman I, Said DG, Maharajan SV, Dua HS. Outcomes of deep anterior lamellar keratoplasty following successful and failed 'big bubble'. Br J Ophthalmol. 2012 Apr;96(4):564-9. doi: 10.1136/bjophthalmol-2011-300214. Epub 2011 Dec 1.</citation>
    <PMID>22133987</PMID>
  </reference>
  <reference>
    <citation>Arnalich-Montiel F, Hernández-Verdejo JL, Oblanca N, Muñoz-Negrete FJ, De Miguel MP. Comparison of corneal haze and visual outcome in primary DSAEK versus DSAEK following failed DMEK. Graefes Arch Clin Exp Ophthalmol. 2013 Nov;251(11):2575-84. doi: 10.1007/s00417-013-2460-y. Epub 2013 Sep 6.</citation>
    <PMID>24008847</PMID>
  </reference>
  <reference>
    <citation>Ivarsen A, Hjortdal J. Recipient corneal thickness and visual outcome after Descemet's stripping automated endothelial keratoplasty. Br J Ophthalmol. 2014 Jan;98(1):30-4. doi: 10.1136/bjophthalmol-2013-304042. Epub 2013 Oct 16.</citation>
    <PMID>24133026</PMID>
  </reference>
  <reference>
    <citation>Gutiérrez R, Lopez I, Villa-Collar C, González-Méijome JM. Corneal transparency after cross-linking for keratoconus: 1-year follow-up. J Refract Surg. 2012 Nov;28(11):781-6. doi: 10.3928/1081597X-20121011-06.</citation>
    <PMID>23347372</PMID>
  </reference>
  <reference>
    <citation>Greenstein SA, Fry KL, Bhatt J, Hersh PS. Natural history of corneal haze after collagen crosslinking for keratoconus and corneal ectasia: Scheimpflug and biomicroscopic analysis. J Cataract Refract Surg. 2010 Dec;36(12):2105-14. doi: 10.1016/j.jcrs.2010.06.067.</citation>
    <PMID>21111314</PMID>
  </reference>
  <reference>
    <citation>Otri AM, Fares U, Al-Aqaba MA, Dua HS. Corneal densitometry as an indicator of corneal health. Ophthalmology. 2012 Mar;119(3):501-8. doi: 10.1016/j.ophtha.2011.08.024. Epub 2011 Nov 30.</citation>
    <PMID>22133793</PMID>
  </reference>
  <reference>
    <citation>Elflein HM, Hofherr T, Berisha-Ramadani F, Weyer V, Lampe C, Beck M, Pitz S. Measuring corneal clouding in patients suffering from mucopolysaccharidosis with the Pentacam densitometry programme. Br J Ophthalmol. 2013 Jul;97(7):829-33. doi: 10.1136/bjophthalmol-2012-302913. Epub 2013 May 17.</citation>
    <PMID>23685998</PMID>
  </reference>
  <verification_date>September 2014</verification_date>
  <study_first_submitted>September 17, 2014</study_first_submitted>
  <study_first_submitted_qc>September 17, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 19, 2014</study_first_posted>
  <last_update_submitted>September 17, 2014</last_update_submitted>
  <last_update_submitted_qc>September 17, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 19, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University Hospitals Cleveland Medical Center</investigator_affiliation>
    <investigator_full_name>Angela Zhu</investigator_full_name>
    <investigator_title>Medical student</investigator_title>
  </responsible_party>
  <keyword>Disability glare</keyword>
  <keyword>Corneal scar</keyword>
  <keyword>Corneal haze</keyword>
  <keyword>Scheimpflug densitometry</keyword>
  <keyword>Contrast sensitivity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vision Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

